Chronic myeloid leukemia of thrombocythemic onset: A CML subtype with distinct hematological and molecular features?

Leukemia

Volumn 10, Issue 7, 1996, Pages 1241-1243

  Cervantes, F ^a,b   Colomer, D ^a   Vives Corrons, J L ^a   Rozman, C ^a   Montserrat, E ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Chronic myeloid leukemia; Essential thrombocythemia; Molecular studies

Indexed keywords

BCR ABL PROTEIN; MESSENGER RNA;

ARTICLE; BLAST CELL CRISIS; BONE MARROW CELL; CHRONIC MYELOID LEUKEMIA; HUMAN; HUMAN CELL; LEUKOCYTOSIS; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOSIS;

EID: 0030035440     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Dreazen O, Canaani E, Gale RP. Molecular biology of chronic myelogenous leukemia. Semin Hematol 1988; 25: 35-49.
2. Shtivelman E, Gale RP, Dreazen O. bcr-abl RNA in chronic myelogenous leukemia. Blood 1987; 69: 971-973.
3. Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. New Engl J Med 1988; 319: 990-998.
4. Inokuchi K et al. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia. Blood 1991; 78: 3125-3127.
5. Inokuchi K, Nomura T. The relationship between the type of bcr/abl hybrid messenger RNA and thrombopoiesis in Philadelphia-positive chronic myelogenous leukemia. Leuk Lymphoma 1993; 10: 9-15.
6. Opalka B et al. No correlation between the type of bcr-abl hybrid messenger RNA and platelet counts in chronic myelogenous leukemia. Blood 1992; 80: 1854-1855 (letter).
7. Shepherd P, Bond C, Allan NC. Molecular breakpoints and platelet counts in chronic myeloid leukemia. Blood 1992; 80: 556-557 (letter).
8. Rozman C et al. Analysis of the clinical relevance of the break-point location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia. Leukemia 1995; 9: 1104-1107.
9. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Chronic myeloid leukemia, BCR/ABL transcript, response to alpha-interteron and survival. Leukemia 1995; 9: 1648-1652.
10. Verhest A, Monsieur R. Philadelphia chromosome-positive thrombocythemia with leukemic transformation. New Engl J Med 1983; 308: 1603.
11. Michiels JJ, Prins ME, Hagemeijer A, Brederoo P, Van der Meulen J, Van Vliet H, Abels J. Philadelphia chromosome-positive thrombocythemia and megakaryoblast leukemia. Am J Clin Pathol 1987; 88: 645-652.
12. Morris CM, Fitzgerald PH, Hollings PE, Archer SA, Rosman I, Beard MJ. Essential thrombocythaemia and the Philadelphia chromosome. Br J Haematol 1988; 70: 13-19.
13. Stoll DB et al. Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome. Am J Hematol 1988; 27: 77-83.
14. Martiat Ph, Ifrah N, Rassool F, Morgan G, Giles F, Gow J, Goldman JM. Molecular analysis of Philadelphia-positive essential thrombocythemia. Leukemia 1989; 3: 563-565.
15. Sarode R, Marwaha N, Gupta RK, Garewal G. Philadelphia chromosome in essential thrombocythemia? (letter). Am J Hematol 1989; 30: 45.
16. Cervantes F et al. Ph-positive chronic myeloid leukemia mimicking essential thrombocythemia and terminating into megakaryoblastic blast crisis: report of two cases with molecular studies. Leukemia 1993; 7: 327-330.
17. Chomcynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
18. Morgan C, Hernández A, Chan LC, Hughes T, Martiat P, Wiedemann LM. The role of alternative splicing patterns of BCR/ABL transcripts in the generation of the blast crisis of chronic myeloid leukaemia. Br J Haematol 1990; 76: 33-38.
19. Hughes TP, Morgan GJ, Martiat P, Goldman JM. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood 1991; 77: 874-878.
20. Murphy S, Iland H, Laszlo J. Essential thrombocythaemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 1986; 23: 177-182.
21. Tobelem G. Essential thrombocythemia. Baillière's Clin Haematol 1989; 2: 719-728.
22. Rozman C, Giralt M, Feliu E, Rubio D, Cortés MT. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 1991; 67: 2658-2668.